"Robotic fatigue?" - The impact of case order on positive surgical margins in robotic-assisted laparoscopic prostatectomy.


Journal

Urologic oncology
ISSN: 1873-2496
Titre abrégé: Urol Oncol
Pays: United States
ID NLM: 9805460

Informations de publication

Date de publication:
06 2021
Historique:
received: 13 07 2020
revised: 08 10 2020
accepted: 23 10 2020
pubmed: 9 11 2020
medline: 15 12 2021
entrez: 8 11 2020
Statut: ppublish

Résumé

Multiple robotic-assisted surgeries are often performed within a single operating day; however, the impact of this practice on patient outcomes has not been examined. We aim to determine whether outcomes for robotic-assisted laparoscopic prostatectomy (RALP) differed when performed sequentially. A multi-institutional, retrospective cohort study was conducted involving a total of 8 academic centers between years 2015 and 2018. Participants were adult males undergoing RALP for localized prostate cancer on operative days in which 2 RALP cases were performed sequentially by the same resident-attending team. The primary outcome of the study was presence of positive surgical margin (PSM). Secondary outcomes were lymph node yield, operative time, and estimated blood loss. The primary analysis was a random effects meta-analysis model for PSM. Overall, 898 RALP cases (449 sequential pairs) were included in the study. There was no significant difference in PSM rate (27.2% vs. 30.3%, P= 0.338) between first and second case groups, respectively. Utilizing random effects meta-analysis, the second case cohort had no increased risk of PSM (OR Case sequence was not associated with PSM, lymph node yield, or operative time for RALP. Disease specific factors and institutional experience are associated with increased risk for positive surgical margin which can aid providers in scheduling of patients.

Identifiants

pubmed: 33160844
pii: S1078-1439(20)30561-5
doi: 10.1016/j.urolonc.2020.10.071
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

365.e17-365.e23

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Laura Bukavina (L)

Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, OH; Case Western Reserve University School of Medicine, Cleveland, OH; Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH.

Kirtishri Mishra (K)

Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, OH; Case Western Reserve University School of Medicine, Cleveland, OH; Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH.

Amr Mahran (A)

Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, OH; Case Western Reserve University School of Medicine, Cleveland, OH.

Austin Fernstrum (A)

Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, OH; Case Western Reserve University School of Medicine, Cleveland, OH; Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH.

Al Ray (A)

Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, OH; Case Western Reserve University School of Medicine, Cleveland, OH; Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH.

Sarah Markt (S)

Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH.

Fredrick Schumacher (F)

Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH; Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH.

Britt Conroy (B)

Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, OH; Case Western Reserve University School of Medicine, Cleveland, OH; Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH.

Robert Abouassaly (R)

Cleveland Clinic Foundation, Lerner College of Medicine, Cleveland, OH; Louis Stokes Cleveland VA Medical Center, Cleveland, OH.

Gregory MacLennan (G)

Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, OH.

Garrett Smith (G)

Department of Urology, State University of New York (SUNY) Upstate Medical University, Syracuse, NY.

Elizabeth Ferry (E)

Department of Urology, State University of New York (SUNY) Upstate Medical University, Syracuse, NY.

Daniel Wong (D)

Department of Urology, University of Texas Southwestern Medical Center (UTSW), Dallas, TX.

Yair Lotan (Y)

Department of Urology, University of Texas Southwestern Medical Center (UTSW), Dallas, TX.

Hemant Chaparala (H)

Ohio State University Wexner Medical Center, Columbus, OH.

David Sharp (D)

Ohio State University Wexner Medical Center, Columbus, OH.

Kareem Alazem (K)

Lahey Hospital and Medical Center, Urology Institute, Burlington, MA.

Alireza Moinzadeh (A)

Lahey Hospital and Medical Center, Urology Institute, Burlington, MA.

Brittany Adamic (B)

Department of Urology, University of Chicago, Chicago, IL.

Gregory Zagaja (G)

Department of Urology, University of Chicago, Chicago, IL.

Puneet Kang (P)

Northeast Ohio Medical University (NEOMED), Rootstown, OH.

Holly Lawry (H)

Department of Urology, University of Arizona College of Medicine, Tucson, AZ.

Benjamin Lee (B)

Department of Urology, University of Arizona College of Medicine, Tucson, AZ.

Adam Calaway (A)

Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, OH; Case Western Reserve University School of Medicine, Cleveland, OH; Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH.

Lee Ponsky (L)

Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, OH; Case Western Reserve University School of Medicine, Cleveland, OH; Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH. Electronic address: Lee.Ponsky@UHhospitals.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH